UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$511.53 USD
+7.17 (1.42%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $511.53 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
UnitedHealth Group (UNH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$581.55 | $675.00 | $481.00 | 15.30% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for UnitedHealth Group comes to $581.55. The forecasts range from a low of $481.00 to a high of $675.00. The average price target represents an increase of 15.3% from the last closing price of $504.36.
Analyst Price Targets (22)
Broker Rating
UnitedHealth Group currently has an average brokerage recommendation (ABR) of 1.15 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 24 brokerage firms. The current ABR compares to an ABR of 1.15 a month ago based on 24 recommendations.
Of the 24 recommendations deriving the current ABR, 21 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 87.5% and 8.33% of all recommendations. A month ago, Strong Buy made up 87.5%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 21 | 21 | 21 | 18 | 18 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.15 | 1.15 | 1.15 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/11/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/9/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
6/18/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
6/5/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
5/28/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/1/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
4/17/2024 | Piper Sandler | Jessica E Tassan | Strong Buy | Strong Buy |
4/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/12/2024 | Not Identified | Not Identified | Hold | Hold |
4/11/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/8/2024 | Wells Fargo Securities | Stephen Baxter | Strong Buy | Strong Buy |
3/8/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
3/6/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
3/4/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
2/29/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1/15/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
12/25/2023 | Goldman Sachs | Nathan Rich | Strong Buy | Strong Buy |
10/16/2023 | UBS | Kevin Caliendo | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.15 |
ABR (Last week) | 1.15 |
# of Recs in ABR | 24 |
Average Target Price | $580.00 |
LT Growth Rate | 12.30% |
Industry | Medical - HMOs |
Industry Rank by ABR | 177 of 252 |
Current Quarter EPS Est: | 6.65 |